Oclacitinib
N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide
Molecular Identity
Oclacitinib
N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide
PubChem CID: 44631938
2D Structure
Properties
C15H23N5O2S
Molecular Formula
337.40
Molecular Weight
g/mol
337.1572
Exact Mass
Da
1.7
XLogP
Drug-like (Lipinski: < 5)
99.4
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
487
Complexity
SMILES
Canonical SMILES
SMILES: CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3Isomeric SMILES
SMILES: CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3Synonyms(20)
OCLACITINIB1208319-26-9PF-03394197JAKIPF-03394197(Oclacitinib)N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamideMFCD25976611ApoquelOclacitinib [USAN]N-Methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamideJAK-IOCLACITINIB [INN]SCHEMBL26167399GS5XTB51PF03394197
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Oclacitinib
Loading drug network...